Researcher.Life Logo

Nuclear Medicine Communications : Impact Factor & More

eISSN: 1473-5628pISSN: 0143-3636

Key Metrics

CiteScore
3.1
Impact Factor
< 5
SJR
Q3Radiology, Nuclear Medicine and Imaging
SNIP
0.59
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nuclear Medicine Communications

Nuclear Medicine Communications Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1980
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Nuclear Medicine Communications ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nuclear Medicine Communications

Independent prognostic value and clinical significance of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters in predicting overall survival of patients with glioma.
  • 1 Feb 2026
  • Nuclear medicine communications
Multiparametric prediction of pulmonary occupying lesion benignancy: combining 18 F-fluorodeoxyglucose and 18 F-fluorothymidine PET radiomics with metabolic and clinical features.
  • 1 Feb 2026
  • Nuclear medicine communications
Post-therapy I-131 whole-body scan with SPECT/computed tomography-based mapping of residual metastatic lymph nodes in differentiated thyroid cancer.
  • 1 Feb 2026
  • Nuclear medicine communications
Threshold optimization for lesion size in lutetium-177 single-photon emission computed tomography imaging: a phantom-based evaluation.
  • 1 Feb 2026
  • Nuclear medicine communications
Intraindividual comparison of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP bone scan with SPECT/CT for detecting skeletal metastases in prostate cancer: a prospective concordance study.
  • 1 Feb 2026
  • Nuclear medicine communications
Role of 99m Tc-sestamibi single photon emission computed tomography/computed tomography in the characterization of renal lesions: a prospective observational study.
  • 1 Feb 2026
  • Nuclear medicine communications
Independent prognostic value and clinical significance of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters in predicting overall survival of patients with glioma.
  • 1 Feb 2026
  • Nuclear medicine communications
Multiparametric prediction of pulmonary occupying lesion benignancy: combining 18 F-fluorodeoxyglucose and 18 F-fluorothymidine PET radiomics with metabolic and clinical features.
  • 1 Feb 2026
  • Nuclear medicine communications
Post-therapy I-131 whole-body scan with SPECT/computed tomography-based mapping of residual metastatic lymph nodes in differentiated thyroid cancer.
  • 1 Feb 2026
  • Nuclear medicine communications
Threshold optimization for lesion size in lutetium-177 single-photon emission computed tomography imaging: a phantom-based evaluation.
  • 1 Feb 2026
  • Nuclear medicine communications
Intraindividual comparison of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP bone scan with SPECT/CT for detecting skeletal metastases in prostate cancer: a prospective concordance study.
  • 1 Feb 2026
  • Nuclear medicine communications
Role of 99m Tc-sestamibi single photon emission computed tomography/computed tomography in the characterization of renal lesions: a prospective observational study.
  • 1 Feb 2026
  • Nuclear medicine communications

FAQs on Nuclear Medicine Communications